Adverse Event Report
Unit 603 and 604, 6th Floor, Ryan Vanak Building, No. 18, West Side of Sheikh Baha'i Square, Tehran, Iran
(+98) 21 45395
ColostroSam (colostrum), a nutrient-rich fluid produced by female mammals the few days after giving birth, is loaded with immune, growth and tissue repair factors. It is a complex biological fluid, which helps in the development of immunity in the newborn. It contains significant quantities of complement components that act as natural anti-microbial agents to actively stimulate the maturation of an infant’s immune system. Studies have shown that colostrum is the only natural source of two major growth factors namely, transforming growth factors alpha and beta, and insulin-like growth factors 1 and 2.
• Strengthen the immune system
• Tissue growth and repair
• Improve the digestive system
• Improve muscular strength
Recommended Dose of ColostroSam®:
The recommended dose is 1-2 capsules daily with a sufficient amount of water.
If gastrointestinal side effects are observed on an empty stomach, the capsule should be taken with or after food.
You can consult your doctor to use this product. According to the doctor, the prescription can be different for each person.
Contraindications of ColostroSam®:
Contraindications other than cow´s milk allergy have not been identified.
Adverse Reactions of ColostroSam®:
ColostroSam® is well tolerated, with minor GI complaints (e.g., nausea, flatulence, diarrhea), and skin rash occurring infrequently.
The collected colostrum from milking the healthy cows is poured into sterile containers and immediately transferred to -18ºC freezers in order to prevent the growth of microorganisms. The defrosting process is performed at the temperature of 37 ºC. After this procedure, the defrosted product is transferred to the separator for degreasing. Degreasing improves the product's stability and shelf life. At this time, the sampling procedures for in-process quality control (IPQC) are performed to ensure that the degreasing process was accurate.
For adverse event report and contact with patient support unit
Immunogenicity and safety of a bivalent, adjuvant system 04–adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15–25: a randomized, double-blind, phase III, noninferiority clinical trial
Evaluation of the safety and efficacy of a biosimilar abobotulinum toxin type A in treating moderate-to-severe glabellar lines: A non-inferiority double blinded randomized controlled trial
Arta Pharmed Company, located in Tehran, Iran, is one of the new pharmaceutical companies that focuses on clinical studies, sales, marketing, market development, market access and scientific activities. This company, which was established in 2018, currently cooperates with more than 15 companies in various fields.
Unit 603 and 604, 6th Floor, Rayan Vanak Building, No. 18, West Side of Sheikh Bahaei Square, Tehran, Iran
Copyright © 2022 Arta Pharmed
Developed by "Arta Pharmed-Technical Dep."